Exploring the impact of insufficient thermal ablation on hepatocellular carcinoma: NDST2 overexpression mechanism and its role in facilitating growth and invasion of residual cancer cells

References

• Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):1. doi: 10.1016/j.bbcan.2019.188314.
   Web of Science ®Google Scholar
• Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, et al. MicroRNA signature in liver cancer. Pathol Res Pract. 2021;219:153369. doi: 10.1016/j.prp.2021.153369.
   PubMed Web of Science ®Google Scholar
• Salazar J, Le A. The heterogeneity of liver cancer metabolism. Adv Exp Med Biol. 2021;1311:127–13. doi: 10.1007/978-3-030-65768-0_9.
   PubMed Web of Science ®Google Scholar
• Feng M, Pan Y, Kong R, et al. Therapy of primary liver cancer. Innovation . 2020;1(2):100032. doi: 10.1016/j.xinn.2020.100032.
   Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi: 10.1038/s41572-020-00240-3.
   PubMed Web of Science ®Google Scholar
• Bo XW, Sun LP, Yu SY, et al. Thermal ablation and immunotherapy for hepatocellular carcinoma: recent advances and future directions. World J Gastrointest Oncol. 2021;13(10):1397–1411. doi: 10.4251/wjgo.v13.i10.1397.
   PubMed Web of Science ®Google Scholar
• Langenbach MC. RFA vs resection of HCC: exploring the past to improve the future. Eur Radiol. 2019;29(5):2677–2678. doi: 10.1007/s00330-019-6000-y.
   PubMed Web of Science ®Google Scholar
• Zeng X, Liao G, Li S, et al. Eliminating METTL1-mediated accu­mulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 2023;77(4):1122–1138. doi: 10.1002/hep.32585.
   PubMed Web of Science ®Google Scholar
• Zhu S, Wu Y, Zhang X, et al. Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Mol Ther. 2023;31(6):1596–1614. doi: 10.1016/j.ymthe.2022.08.004.
   PubMed Web of Science ®Google Scholar
• Herrera-Heredia SA, Hsu HP, Kao CY, et al. Heparin is required for the formation of granules in connective tissue mast cells. Front Immunol. 2022;13:1000405. doi: 10.3389/fimmu.2022.1000405.
   PubMed Web of Science ®Google Scholar
• Atallah J, Khachfe HH, Berro J, et al. The use of heparin and heparin-like molecules in cancer treatment: a review. Cancer Treat Res Commun. 2020;24:100192. doi: 10.1016/j.ctarc.2020.100192.
   PubMedGoogle Scholar
• Wang XD, Peng JB, Zhou CY, et al. Potential therapies for residual hepatoblastoma following incomplete ablation treatment in a nude mouse subcutaneous xenograft model based on lncRNA and mRNA expression profiles. Oncol Rep. 2020;43(6):1915–1927. doi: 10.3892/or.2020.7545.
   PubMed Web of Science ®Google Scholar
• Bi F, Chen Y, Yang Q. Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer. Cancer Cell Int. 2020;20(1):373. doi: 10.1186/s12935-020-01472-9.
   PubMed Web of Science ®Google Scholar
• Wen T, Xie P, Yang S, et al. ggClusterNet: an R package for microbiome network analysis and modularity-based multiple network layouts. iMeta. 2022;1(3):e32. doi: 10.1002/imt2.32.
   Google Scholar
• Guo Y, Ren Y, Dong X, et al. An overview of hepatocellular carcinoma after insufficient radiofrequency ablation. J Hepatocell Carcinoma. 2022;9:343–355. doi: 10.2147/JHC.S358539.
   PubMed Web of Science ®Google Scholar
• Wang L, Li S, Luo H, et al. PCSK9 promotes the progression and metastasis of Colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res. 2022;41(1):303. doi: 10.1186/s13046-022-02477-0.
   PubMed Web of Science ®Google Scholar
• Justus CR, Marie MA, Sanderlin EJ, et al. Transwell in vitro cell migration and invasion assays. Methods Mol Biol. 2023;2644:349–359. doi: 10.1007/978-1-0716-3052-5_22.
   PubMedGoogle Scholar
• Martinotti S, Ranzato E. Scratch wound healing assay. Methods Mol Biol. 2020;2109:225–229. doi: 10.1007/7651_2019_259.
   PubMedGoogle Scholar
• Xing M, Wang X, Kiken RA, et al. Immunodiagnostic biomarkers for hepatocellular carcinoma (HCC): the first step in detection and treatment. Int J Mol Sci. 2021;22(11):6139. doi: 10.3390/ijms22116139.
   PubMed Web of Science ®Google Scholar
• Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308–319. doi: 10.1016/j.gendis.2020.01.014.
   PubMed Web of Science ®Google Scholar
• Jin Q, Chen X, Zheng S. The security rating on local ablation and interventional therapy for hepatocellular carcinoma (HCC) and the comparison among multiple anesthesia methods. Anal Cell Pathol . 2019;2019:2965173. doi: 10.1155/2019/2965173.
   Web of Science ®Google Scholar
• Granata V, Grassi R, Fusco R, et al. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer. 2021;16(1):53.
   PubMed Web of Science ®Google Scholar
• Markezana A, Ahmed M, Kumar G, et al. Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity. Int J Hyperthermia. 2020;37(1):119–129. doi: 10.1080/02656736.2020.1714084.
   PubMed Web of Science ®Google Scholar
• Markezana A, Paldor M, Liao H, et al. Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation. Sci Rep. 2023;13(1):16341. doi: 10.1038/s41598-023-42819-2.
   PubMed Web of Science ®Google Scholar
• Carlsson P, Presto J, Spillmann D, et al. Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. J Biol Chem. 2008;283(29):20008–20014. doi: 10.1074/jbc.M801652200.
   PubMed Web of Science ®Google Scholar
• Pikas DS, Eriksson I, Kjellén L. Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns. Biochemistry. 2000;39(15):4552–4558. doi: 10.1021/bi992524l.
   PubMed Web of Science ®Google Scholar
• Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677–685. doi: 10.1038/ncb2502.
   PubMed Web of Science ®Google Scholar
• Korhan P, Yılmaz Y, Bağırsakçı E, et al. Pleiotropic effects of ­heparins: from clinical applications to molecular mechanisms in hepatocellular carcinoma. Can J Gastroenterol Hepatol. 2018;2018:7568742–7568748. doi: 10.1155/2018/7568742.
   PubMed Web of Science ®Google Scholar
• Cheng K, Cai N, Zhu J, et al. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun. 2022; 42(11):1112–1140. doi: 10.1002/cac2.12345.
   Web of Science ®Google Scholar
• Yu D, Walker LSK, Liu Z, et al. Targeting TFH cells in human diseases and vaccination: rationale and practice. Nat Immunol. 2022;23(8):1157–1168. doi: 10.1038/s41590-022-01253-8.
   PubMed Web of Science ®Google Scholar
• Nakato R, Sakata T. Methods for ChIP-seq analysis: a practical workflow and advanced applications. Methods. 2021;187:44–53. doi: 10.1016/j.ymeth.2020.03.005.
   PubMed Web of Science ®Google Scholar
• Canete-Portillo S, Velazquez EF, Kristiansen G, et al. Report from the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers V: recommendations on the use of immunohistochemical and molecular biomarkers in penile cancer. Am J Surg Pathol. 2020;44(7):e80–e86. doi: 10.1097/PAS.0000000000001477.
   PubMed Web of Science ®Google Scholar